...
首页> 外文期刊>Journal of Clinical and Diagnostic Research >Gigantic Pulmonary ArteriovenousMalformation Presenting as Recurrent Lung Infectio
【24h】

Gigantic Pulmonary ArteriovenousMalformation Presenting as Recurrent Lung Infectio

机译:巨大的肺动脉畸形呈现为复发性肺部感染

获取原文
   

获取外文期刊封面封底 >>

       

摘要

The abnormal connection between pulmonary arterial and venous circulation is known as Pulmonary Arteriovenous Malformation (PAVM). It was first described by Churton in 1897. The presentation varies from incidental findings to shortness of breath, haemoptysis, chest pain, syncope and cyanosis. Patients with hereditary haemorrhagic telangiectasia are prone to develop PAVM. PAVMs are quite rare, the frequency ranges from 2-3 per 1,00,000 population. Treatment options include surgical intervention and embolisation, the former is now used seldom. The surgical intervention is more invasive than the percutaneous intervention procedure also known as embolotherapy or embolisation. In the present case, authors encountered a rare case of a 30-yearold male presented with giant PAVM with 13 mm diameter (60.65?—35.32 mm in dimensions), where patient presented with fever since two months and vomiting. Considering his symptoms, he was initially suspected as Coronavirus-2019 (COVID-19) positive. However, his Reverse Transcription-Polymerase Chain Reaction (RT-PCR) test was reported negative. It was decided to treat him with vascular plug embolisation. A 16 mm Ampletzer vascular plug II was deployed in such a way that it does not occlude the lower branches of Left Pulmonary Artery (LPA). After deploying the vascular plug, the patient was stable and tolerated the procedure well. He was discharged after two days of observation considering his haemodynamic stability.
机译:肺动脉和静脉循环之间的异常联系称为肺动脉畸形(PAVM)。它是Churton于1897年由Churton描述的。介绍因涉及呼吸急促,血肿,胸痛,晕厥和紫绀而异。患有遗传性出血性毛细血管直学患者的患者易于开发帕夫。 Pavms非常罕见,频率范围为每1,00,000人口2-3。治疗方案包括外科手术和栓塞,前者现在很少使用。外科手术干预比均被称为栓塞疗法或栓塞的经皮干预程序更具侵入性。在本案中,作者遇到了一个罕见的案例,含有13毫米直径(尺寸60.65?-35.32毫米的巨型馆的30岁男性,其中患者自两个月以来发烧并呕吐。考虑到他的症状,他最初怀疑是冠状病毒 - 2019(Covid-19)积极。然而,据报道,他的逆转录聚合酶链反应(RT-PCR)试验是阴性的。决定用血管栓塞栓塞治疗他。展开16mm的扩增仪血管塞II,使得它不会遮挡左肺动脉(LPA)的下部分支。在部署血管插头后,患者稳定并耐受该过程。考虑到他的血液动力学稳定,他在观察后两天后出院。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号